Medical diagnostics

Transforming medical diagnostics with exceptional sensitivity

Medical diagnostics is on the cusp of transformation. Canatu’s carbon nanotube (CNT) platform is being developed to deliver next-generation electrochemical sensing solutions that are more sensitive and accessible. Our unique CNT technology aims to enable the detection of severe infections and diseases, such as cancer, at their earliest stages—positioning the platform to support future patient outcomes, monitoring, and safety.

Healthcare industry trends

Healthcare is moving toward faster and more accessible diagnostics, driving the need for highly sensitive sensing technologies capable of detecting biomarkers from increasingly small sample volumes and at earlier stages of disease progression.

  • Early detection of diseases
  • Point-of-care testing
  • Specialized disease-specific biomarkers

CNT biosensor platform technology

  • Sensitive: Demonstrated >10x increased sensitivity in preliminary research in vitro matrices (internal, unpublished data)
  • Versatile: An adaptable platform technology customizable for target analytes of interest
  • At scale: Leveraging our proven industrial expertise to scale future medical sensor production to tens of millions of units annually

Lab in hand enables informed decisions at point-of-care

Medical diagnostics is entering a new phase of innovation—driven by the need for faster, more sensitive, and more accessible detection technologies. Testing is shifting from centralized to point-of-care, enabling simple testing and quick results in minutes. Electrochemical biosensors are at the forefront of this transformation. They provide quantitative detection of any desired analyte at the point of care. Multiple biomarkers can be tested simultaneously. This technology concept is intended to empower future caregivers to make rapid decisions at the point-of-care, optimizing patient pathways and healthcare efficiency.

Transforming medical diagnostics at the point of care using exceptionally sensitive electrochemical biosensors from Canatu

Watch the video on our CNT biosensor technology

Our technology platforms

Electrochemical sensors for point of use diagnostics from Canatu
Electrochemical biosensors

Electrochemical biosensor concepts under development for point-of-use diagnostics aims to enable the detection of severe infections and diseases, such as cancer, at their earliest stages.

Learn more
Electrochemical sensors

Electrochemical sensors concepts offer high sensitivity that enables detection of substances at extremely low concentrations, with potential applications in veterinary care, environmental monitoring, food & beverages, and beyond.

Learn more

Regulatory Status Notice: Canatu’s electrochemical sensor solutions for medical diagnostics are currently in the concept and feasibility development phase. These technology concepts, components, and provisional specifications are intended exclusively for research, evaluation, and co-development partnership purposes. They are not cleared or approved by any regulatory authority for clinical diagnostic use, nor are they commercially available as medical devices. All technical parameters are provisional and subject to verification within design control phases.

Download technical overview

We are looking to partner with early-stage development collaborators and frontrunners ready to transform medical diagnostics at the point of care. Download provisional technical capabilities.

Our latest research with ecosystem partners and academia:

Introduction of an electrochemical point-of-care assay for quantitative determination of paracetamol in finger-prick capillary whole blood samples

Rapid industrial scale synthesis of robust carbon nanotube network electrodes for electroanalysis

Real-time selective detection of dopamine and serotonin at nanomolar concentration from complex in vitro systems

Ascorbic acid does not necessarily interfere with the electrochemical detection of dopamine

Electrochemical Detection of Oxycodone and Its Main Metabolites with Nafion-Coated Single-Walled Carbon Nanotube Electrodes

Disposable Nafion-Coated Single-Walled Carbon Nanotube Test Strip for Electrochemical Quantitative Determination of Acetaminophen in a Finger-Prick Whole Blood Sample

Electrochemical Detection of Morphine in Untreated Human Capillary Whole Blood

Effect of Electrochemical Oxidation on Physicochemical Properties of Fe-Containing Single-Walled Carbon Nanotubes

Contact our specialist in medical diagnostics

Nedal Safwat, Chief Development Officer of Canatu Plc
Nedal Safwat
Senior Vice President, Medical Diagnostics
nedal.safwat@canatu.com +1-919-452-8721

Send us a message

We are looking to partner with frontrunners ready to transform medical diagnostics at the point of care. If you’re interested in exploring this opportunity further, contact our CTO Ilkka Varjos.